Rethymic

allogeneic processed thymus tissue – agdc

Approval

ApplicationBLA 125685
Approval dateOct 8, 2021
Approval year2021
SponsorEnzyvant Therapeutics GmbH

FDA-approved use

For immune reconstitution in pediatric patients with congenital athymia

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Rethymic: